Snehaa Organics Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 126,000 (5%) | — | ₹15 Cr |
| NII (HNI) | — | 1,209,000 (45%) | — | ₹1,475 Cr |
| Retail | — | 1,210,000 (45%) | — | ₹1,476 Cr |
| Market Maker | — | 134,000 (5%) | — | ₹16 Cr |
| Σ Total | — | 2,679,000 (100%) | — | ₹32,684 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,000 | ₹122,000 |
| Retail (Max) | 13 | 13,000 | ₹1,586,000 |
| S-HNI (Min) | 14 | 14,000 | ₹1,708,000 |
| B-HNI (Min) | 67 | 67,000 | ₹8,174,000 |
Financial Statements Amount in Crore
| Metric | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Revenue | 26 | 24 | 20 |
| EBITDA | 11 | 6 | 4 |
| Profit After Tax | 7 | 4 | 3 |
| Net Worth | 15 | 7 | 4 |
| Total Assets | 30 | 17 | 11 |
| Reserves & Surplus | 7 | 6 | 3 |
| Total Borrowing | 9 | 4 | 4 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 Working Capital Requirement – 23.94
- 2 To Repayment of loans availed by the Company – 3.50
- 3 General Corporate Purposes – 1.97
- 4 Issue expenses – 3.27
Company Overview
Incorporated in October 2017, Snehaa Organics Limited operates in solvent recovery, providing sustainable solutions for industries that use solvents.
The company collects spent solvents and uses distillation and purification technologies to reuse them.
Its workforce ensures efficient recovery from diverse solvent mixtures with high batch variability.
The company trades solvents directly, sourcing raw materials, assessing quality, and selling in the open market.
It has a manufacturing facility in Hyderabad, Telangana across 3,300 sq. ft.
Competitive Strength:
- Modern technology and infrastructure for solvent recovery processes
- Good reputation in the Pharmaceutical sector.
- Strategic location